ONCODESIGN
Develops therapeutic and diagnostic solutions for resistant and metastatic cancers.
ALONC | PA
Overview
Corporate Details
- ISIN(s):
- FR0011766229
- LEI:
- 9695004HPDBVG72O8851
- Country:
- France
- Address:
- 20 RUE JEAN MAZEN, 21000 DIJON
- Website:
- https://www.oncodesign.com/
Description
Oncodesign Precision Medicine is a biotechnology company specializing in precision medicine. Its mission is to develop and deliver innovative therapeutic and diagnostic solutions to treat resistant and metastatic cancers. The company utilizes a unique, patient-centric model and a proprietary technology platform to discover and advance effective treatments. This approach is centered on translational thinking, aiming to address the challenges of therapeutic resistance and metastasis evolution by focusing on unmet patient needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-10-05 08:00 |
Communicated under the obligation to provide permanent information / Activity o…
|
English | 404.7 KB | ||
| 2017-09-28 19:03 |
Rapport financier semestriel
|
French | 2.6 MB | ||
| 2017-08-31 18:00 |
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
|
French | 445.9 KB | ||
| 2017-08-31 18:00 |
Communicated under the obligation to provide permanent information / Activity o…
|
English | 433.1 KB | ||
| 2017-07-17 18:00 |
Rachat d'actions / Contrat de liquidité Information relative au contrat de liqu…
|
French | 331.7 KB | ||
| 2017-05-29 23:59 |
Communiqués de mise à disposition de documents / Modalités de mise à dispositio…
|
French | 384.9 KB | ||
| 2017-05-29 20:49 |
Rapport financier annuel
|
French | 2.5 MB | ||
| 2017-05-10 18:30 |
Communicated under the obligation to provide permanent information / Activity o…
|
English | 337.5 KB | ||
| 2017-05-10 18:30 |
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
|
French | 351.8 KB | ||
| 2017-04-03 07:30 |
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
|
French | 672.0 KB | ||
| 2017-04-03 07:30 |
Communicated under the obligation to provide permanent information / Activity o…
|
English | 461.1 KB | ||
| 2017-03-15 17:45 |
Communicated under the obligation to provide permanent information / Activity o…
|
English | 430.3 KB | ||
| 2017-03-15 17:45 |
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
|
French | 442.1 KB | ||
| 2017-03-09 08:00 |
Rachat d'actions / Contrat de liquidité Information relative au contrat de liqu…
|
French | 380.4 KB | ||
| 2017-02-07 18:00 |
Communicated under the obligation to provide permanent information / Activity o…
|
English | 279.3 KB |
Automate Your Workflow. Get a real-time feed of all ONCODESIGN filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ONCODESIGN
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ONCODESIGN via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
